Literature DB >> 19414550

Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media.

Fengchan Han1, Heping Yu, Cong Tian, Shengli Li, Michael R Jacobs, Cindy Benedict-Alderfer, Qing Y Zheng.   

Abstract

Streptococcus pneumoniae is the most common pathogen associated with otitis media. To examine the role of Toll-like receptor 2 (TLR2) in host defense against Streptococcus pneumoniae infection in the middle ear, wild-type (WT; C57BL/6) and TLR2-deficient (TLR2(-/-)) mice were inoculated with Streptococcus pneumoniae (1 x 10(6) CFU) through the tympanic membrane. Nineteen of 37 TLR2(-/-) mice showed bacteremia and died within 3 days after the challenge, compared to only 4 of 32 WT mice that died. Of those that survived, more severe hearing loss in the TLR2(-/-) mice than in the WT mice was indicated by an elevation in auditory-evoked brain stem response thresholds at 3 or 7 days postinoculation. The histological pathology was characterized by effusion and tissue damage in the middle ear, and in the TLR2(-/-) mice, the outcome of infection became more severe at 7 days. At both 3 and 7 days postchallenge, the TLR2(-/-) mice had higher blood bacterial titers than the WT mice (P < 0.05), and typical bacteria were identified in the effusion from both ears of both mouse groups by acridine orange staining. Moreover, by 3 days postchallenge, the mRNA accumulation levels of NF-kappaB, tumor necrosis factor alpha, interleukin 1beta, MIP1alpha, Muc5ac, and Muc5b were significantly lower in the ears of TLR2(-/-) mice than in WT mice. In summary, TLR2(-/-) mice may produce relatively low levels of proinflammatory cytokines following pneumococcal challenge, thus hindering the clearance of bacteria from the middle ear and leading to sepsis and a high mortality rate. This study provides evidence that TLR2 is important in the molecular pathogenesis and host response to otitis media.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414550      PMCID: PMC2708554          DOI: 10.1128/IAI.00204-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis.

Authors:  Dae Hoon Kim; Ho-Suk Chu; Jin Young Lee; Soon Jae Hwang; Sang Hag Lee; Heung-Man Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-06

3.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Authors:  A Yoshimura; E Lien; R R Ingalls; E Tuomanen; R Dziarski; D Golenbock
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

4.  Pneumococcus activation of the 5-lipoxygenase pathway and production of glycoproteins in the middle ear of rats.

Authors:  J Lin; A Vambutas; A Haruta; M M Paparella; G S Giebink; Y Kim
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses.

Authors:  Q Y Zheng; K R Johnson; L C Erway
Journal:  Hear Res       Date:  1999-04       Impact factor: 3.208

6.  Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.

Authors:  Mihai G Netea; Gerben Ferwerda; Dirk J de Jong; Trees Jansen; Liesbeth Jacobs; Matthijs Kramer; Ton H J Naber; Joost P H Drenth; Stephen E Girardin; Bart Jan Kullberg; Gosse J Adema; Jos W M Van der Meer
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  A mouse model for acute otitis media.

Authors:  Asa Melhus; Allen F Ryan
Journal:  APMIS       Date:  2003-10       Impact factor: 3.205

8.  Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae.

Authors:  Bastian Opitz; Anja Püschel; Bernd Schmeck; Andreas C Hocke; Simone Rosseau; Sven Hammerschmidt; Ralf R Schumann; Norbert Suttorp; Stefan Hippenstiel
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

9.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.

Authors:  Michael B Drennan; Delphine Nicolle; Valerie J F Quesniaux; Muazzam Jacobs; Nasiema Allie; Joseph Mpagi; Cécile Frémond; Hermann Wagner; Carsten Kirschning; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Impaired adrenal stress response in Toll-like receptor 2-deficient mice.

Authors:  Stefan R Bornstein; Paula Zacharowski; Ralf R Schumann; Andreas Barthel; Nguyen Tran; Claudia Papewalis; Valeria Rettori; Samuel M McCann; Klaus Schulze-Osthoff; Werner A Scherbaum; Jörg Tarnow; Kai Zacharowski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

View more
  23 in total

1.  Pneumococcal peptidoglycan-polysaccharides regulate Toll-like receptor 2 in the mouse middle ear epithelial cells.

Authors:  Masahiro Komori; Yoshihisa Nakamura; Jesse Ping; Ling Feng; Katsuhiro Toyama; Youngki Kim; Patricia Ferrieri; Jizhen Lin
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

4.  Pathological features in the LmnaDhe/+ mutant mouse provide a novel model of human otitis media and laminopathies.

Authors:  Yan Zhang; Heping Yu; Min Xu; Fengchan Han; Cong Tian; Suejin Kim; Elisha Fredman; Jin Zhang; Cindy Benedict-Alderfer; Qing Yin Zheng
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

5.  Otitis media induced by peptidoglycan-polysaccharide (PGPS) in TLR2-deficient (Tlr2(-/-)) mice for developing drug therapy.

Authors:  Xiaolin Zhang; Tihua Zheng; Lu Sang; Luke Apisa; Hongchun Zhao; Fenghua Fu; Qingzhu Wang; Yanfei Wang; Qingyin Zheng
Journal:  Infect Genet Evol       Date:  2015-08-18       Impact factor: 3.342

6.  TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media.

Authors:  Yifei Huang; Zimeng Wang; Chunfang Jin; Lei Wang; Xuemei Zhang; Wenchun Xu; Yun Xiang; Wei Wang; Xiujing He; Yibing Yin; Yujuan He
Journal:  Pediatr Res       Date:  2016-07-27       Impact factor: 3.756

Review 7.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

8.  Mutation in Phex gene predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media.

Authors:  Fengchan Han; Heping Yu; Ping Li; Jiangping Zhang; Cong Tian; Hongbo Li; Qing Yin Zheng
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Sh3pxd2b mice are a model for craniofacial dysmorphology and otitis media.

Authors:  Bin Yang; Cong Tian; Zhi-guang Zhang; Feng-chan Han; Rami Azem; Heping Yu; Ye Zheng; Ge Jin; James E Arnold; Qing Y Zheng
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 10.  Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.

Authors:  Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.